Not applicableUnknownNCT03692442
What this trial is testing
Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform
Who this might be right for
Lung Cancer Non-small Cell Stage IV
Guangzhou Institute of Respiratory Disease 80